After final $600M opioid settlement, Indivior looks to the f...

UK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in the US behind it, after agreeing a $600 million settlement.

Mallinckrodt proposes $1.6bn deal to settle opioid litigatio...

FDA rejects Adamis opioid overdose therapy Zimhi, hitting sh...

Federal opioid trial averted by last-ditch settlement

Is the US opioid litigation nearing an end game?

Sandoz says ‘no’ to Pear Therapeutics’ digital apps, handing...